HealthEquity Enterprise Value vs Operating Margin Analysis
HQY Stock | USD 80.89 1.04 1.30% |
HealthEquity financial indicator trend analysis is much more than just examining HealthEquity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HealthEquity is a good investment. Please check the relationship between HealthEquity Enterprise Value and its Operating Profit Margin accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
Enterprise Value vs Operating Profit Margin
Enterprise Value vs Operating Margin Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HealthEquity Enterprise Value account and Operating Margin. At this time, the significance of the direction appears to have no relationship.
The correlation between HealthEquity's Enterprise Value and Operating Margin is 0.02. Overlapping area represents the amount of variation of Enterprise Value that can explain the historical movement of Operating Margin in the same time period over historical financial statements of HealthEquity, assuming nothing else is changed. The correlation between historical values of HealthEquity's Enterprise Value and Operating Margin is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Enterprise Value of HealthEquity are associated (or correlated) with its Operating Margin. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Operating Margin has no effect on the direction of Enterprise Value i.e., HealthEquity's Enterprise Value and Operating Margin go up and down completely randomly.
Correlation Coefficient | 0.02 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Enterprise Value
Enterprise Value (or EV) is usually referred to as HealthEquity theoretical takeover price. In the event of an acquisition, an acquirer would have to take on HealthEquity debt, but would also pocket its cash. Enterprise Value is more accurate representation of HealthEquity value than its market capitalization because it takes into account all of HealthEquity existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.Operating Profit Margin
Most indicators from HealthEquity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.08 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 423.7M | 490.1M | 529.9M | 556.4M | Total Revenue | 756.6M | 861.7M | 999.6M | 1.0B |
HealthEquity fundamental ratios Correlations
Click cells to compare fundamentals
HealthEquity Account Relationship Matchups
High Positive Relationship
High Negative Relationship
HealthEquity fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.6B | 2.7B | 3.1B | 3.1B | 3.2B | 3.4B | |
Other Current Liab | 96.7M | 126.2M | 104.7M | 89.5M | 95.6M | 54.8M | |
Total Current Liabilities | 152.1M | 204.3M | 153.2M | 131.1M | 117.1M | 79.0M | |
Total Stockholder Equity | 1.0B | 1.4B | 1.9B | 1.9B | 2.0B | 2.1B | |
Other Liab | 133.1M | 128.5M | 114.0M | 95.4M | 109.7M | 115.2M | |
Accounts Payable | 4.0M | 1.6M | 27.5M | 13.9M | 12.0M | 6.9M | |
Cash | 191.7M | 328.8M | 225.4M | 254.3M | 404.0M | 212.6M | |
Other Assets | 35.1M | 37.4M | 49.8M | 52.2M | 1.0 | 0.95 | |
Good Will | 1.3B | 1.3B | 1.6B | 1.6B | 1.9B | 2.0B | |
Common Stock Shares Outstanding | 68.5M | 75.7M | 83.1M | 84.4M | 87.0M | 68.4M | |
Other Current Assets | 33.8M | 58.6M | 38.5M | 31.8M | 48.6M | 51.0M | |
Total Liab | 1.5B | 1.3B | 1.3B | 1.2B | 1.2B | 609.8M | |
Intangible Assets | 783.3M | 767.0M | 973.1M | 936.4M | 835.9M | 428.2M | |
Property Plant Equipment | 33.5M | 118.6M | 87.0M | 69.3M | 79.7M | 83.7M | |
Property Plant And Equipment Net | 116.7M | 118.6M | 87.0M | 69.3M | 54.4M | 47.5M | |
Net Debt | 1.1B | 746.2M | 782.8M | 740.2M | 529.2M | 299.8M | |
Retained Earnings | 211.5M | 220.3M | 176.1M | 149.9M | 205.6M | 121.8M | |
Non Current Assets Total | 2.3B | 2.2B | 2.8B | 2.7B | 2.7B | 2.8B | |
Cash And Short Term Investments | 191.7M | 328.8M | 225.4M | 254.3M | 404.0M | 243.5M | |
Net Receivables | 70.5M | 72.8M | 87.4M | 96.8M | 104.9M | 52.6M | |
Liabilities And Stockholders Equity | 2.6B | 2.7B | 3.1B | 3.1B | 3.2B | 1.6B | |
Non Current Liabilities Total | 1.4B | 1.1B | 1.1B | 1.1B | 1.1B | 578.7M | |
Other Stockholder Equity | 818.8M | 1.2B | 1.7B | 1.7B | 1.8B | 1.9B | |
Property Plant And Equipment Gross | 116.7M | 118.6M | 87.0M | 69.3M | 95.4M | 51.6M | |
Total Current Assets | 296.0M | 460.2M | 351.3M | 382.9M | 557.4M | 320.0M | |
Net Tangible Assets | (1.1B) | (715.1M) | (766.4M) | (688.9M) | (620.0M) | (589.0M) | |
Non Currrent Assets Other | 35.1M | 37.4M | 49.8M | 52.2M | (768.1M) | (729.7M) | |
Retained Earnings Total Equity | 85.3M | 171.9M | 211.5M | 220.3M | 253.4M | 266.1M | |
Capital Surpluse | 261.2M | 305.2M | 818.8M | 1.2B | 1.3B | 1.4B | |
Non Current Liabilities Other | 1.4B | 8.8M | 14.2M | 12.7M | 19.3M | 18.3M | |
Net Invested Capital | 2.3B | 2.4B | 2.8B | 2.8B | 2.9B | 2.2B | |
Net Working Capital | 145.4M | 255.5M | 198.2M | 251.8M | 440.3M | 298.8M |
HealthEquity Investors Sentiment
The influence of HealthEquity's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in HealthEquity. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to HealthEquity's public news can be used to forecast risks associated with an investment in HealthEquity. The trend in average sentiment can be used to explain how an investor holding HealthEquity can time the market purely based on public headlines and social activities around HealthEquity. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
HealthEquity's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for HealthEquity's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average HealthEquity's news discussions. The higher the estimated score, the more favorable is the investor's outlook on HealthEquity.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards HealthEquity in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, HealthEquity's short interest history, or implied volatility extrapolated from HealthEquity options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index. For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for HealthEquity Stock analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.96) | Earnings Share 0.64 | Revenue Per Share 11.682 | Quarterly Revenue Growth 0.122 | Return On Assets 0.0256 |
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.